Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Pharmacol Sin ; 21(5): 410-4, 2000 May.
Article in English | MEDLINE | ID: mdl-11324437

ABSTRACT

AIM: To understand the mechanism of neurotrophic action of neuropeptide ZNC(C)PR and its effect on which could affect both growth and apoptosis of C6 cells. METHODS: Effects of ZNC(C)PR-treated C6 conditioned medium was observed on on culture of PC12 cells. The development of PC12 cells was determined by ratio of neurite-bearing cells in the total cells. The specific binding of ZNC(C)PR on C6 cells was determined by radioligand binding assay (RBA). RESULTS: ZNC(C)PR-treated C6 conditioned medium increased the ratio of neurite-bearing PC12 cells by 36% compared to the untreated C6 conditioned medium or to a mixture of ZNC(C)PR with the untreated C6 conditioned medium. RBA showed a specific binding site of ZNC(C)PR on C6 cells with Kd value of 2.74 nmol.L-1 and Bmax value of 19 pmol.g-1 protein. CONCLUSION: ZNC(C)PR enhanced C6 cells induced secretion of some neurotrophic factors which acted as enhancers for PC12 cells differentiation, through its specific receptor sites on the neuroglioma cell.


Subject(s)
Arginine Vasopressin/pharmacology , Nerve Growth Factors/pharmacology , Peptide Fragments/pharmacology , Animals , Binding Sites , Brain Neoplasms/pathology , Cell Differentiation , Cell Division , Cell Membrane , Culture Media, Conditioned , Glioma/pathology , PC12 Cells , Rats , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...